Amanda C. Raff
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">Dr. Raff is a Professor of Medicine and the Associate Chair of Medicine for Undergraduate Medical Education. She has been the Course Director for the Einstein first year medical student Renal System Course since 2007 and the Internal Medicine Clerkship and Acting Internship Director since 2012.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">She a faculty mentor for the student led Step 1 Group near-peer evidence based guidance program and the Internal Medicine Interest Group.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">She has a clinical practice of CKD and ESRD patients and enjoys rounding on the inpatient Renal Consult and Dialysis services.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">Dr. Raff’s contributions in the field of Medical Education include serving as a Case Editor for Aquifer Internal Medicine, contributing author and reviewer for the Clerkship Directors in Internal Medicine (CDIM) curriculum revision and MKSAP 19 Nephrology section committee member.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">She has been recognized for her teaching excellence at Einstein with the Samuel M. Rosen Outstanding Teacher Award for Excellence in Basic Science Teaching, the Harry Eagle Award for Outstanding Basic Science Teaching, the Harry H. Gordon Award for Outstanding Clinical Teaching and membership in the Leo M. Davidoff Society.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; line-height: 15.6pt;">Dr. Raff received a bachelor's degree in biology from Indiana University and a MD from Albert Einstein College of Medicine. She completed a residency in Internal Medicine at NewYork Presbyterian Hospital and a chief resident year at NYU Downtown Hospital. She returned to Einstein/Montefiore for a Nephrology Fellowship and joined the Einstein Division of Nephrology faculty in 2004.</p>
Autosomal Dominant Polycystic Kidney Disease (ADPKD)<br />Chronic Kidney Disease (CKD)<br />End Stage Kidney Disease (ESKD, ESRD)<br />Acute Kidney Injury (AKI)<br />Glomerular diseases<br />Hypertension<br />Electrolyte Disorders<br />Kidney Stones<br />
<p><span style="color:black;"> </span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">1. </span><span style="font-size: 12pt; font-family: Cambria; color: #212121;">Fitz M, Adams W, Haist S, Hauer K, Ross P, <strong>Raff A</strong>, Agarwal G, Vu T, Appelbaum J, Lang V, Miller C, Grum C and the Clerkship Directors in Internal Medicine – National Board of Medical Examiners EXPRESS Study Group. Which Internal Medicine Clerkship Characteristics Are Associated With Students' Performance on the NBME Medicine Subject Exam? A Multi-Institutional Analysis. <em>Acad Med</em>. 2020;10.1097/ACM.0000000000003322 [published online ahead of print, 2020 Mar 17]. </span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria; color: #212121;">2. </span><span style="font-size: 12pt; font-family: Cambria;">Brien K (Author), Calvo L (Associate editor), <strong>Raff A</strong> (Case editor). <em>Aquifer Internal Medicine Case 33: 49-year-old woman with confusion</em>. 2019 </span><u><span style="font-size: 12pt; font-family: Cambria; color: #3366ff;">https://www.aquifer.org</span></u></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria; color: #212121;">3. </span><span style="font-size: 12pt; font-family: Cambria;">Khan M, Gil N, Lin W, Fiter R, Kenawy D, Burton W, <strong>Raff A</strong>. The impact of Step 1 scores on medical students’ residency specialty choice. <em>Med Sci Educ.</em> 28(4): 699-705. 2018.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">4. Ludwig A, <strong>Raff A</strong>, Lin J, Schoenbaum E. Group Observed Structured Encounter (GOSCE) for third year medical students improves self-assessment of clinical communication. <em>Medical Teacher</em> 39(9): 931-5. 2017.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">5. Golestaneh L, Neugarten J, Southern W, Kargoli F, <strong>Raff A</strong>. Improving the diagnostic workup of hyponatremia in the setting of kidney disease: a continuing medical education (CME) initiative. <em>Int Urol Nephrol</em> 49(3): 491-7. 2017</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">6. Czapka M, <strong>Raff A</strong>, Risley M. Safe Transitions: An active learning module for discharge summaries and interprofessional care. <em>MedEdPORTAL iCollaborative</em>. 2017</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">7. Tanenbaum, E, Johnson J, Jordan, E, Cottral J, Tenore C, Burton W, McGinn A<strong>, Raff A</strong>. An effective evidence-based student run near-peer support group for the USMLE Step 1 Exam. <em>Med Sci Educ</em>. 26(4): 691-9. 2016</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">8. Ludwig A, Lee R, Parish S, <strong>Raff A</strong>. Four-station group observed structured clinical encounter for formative assessment of communication skills for internal medicine clerks. <em>MedEdPORTAL Publications</em>. 12:10444. 2016 </span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">9. Chen W, Melamed M, Hostetter T, Bauer C, <strong>Raff A</strong>, Almudevar A, Lalonde A, Messing S, Abramowitz M. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study. <em>BMC Nephrol</em>. 17(1): 114. doi: 10.1186/s12882-016-0331-6. 2016</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">10. Jion Y, <strong>Raff A</strong>, Grosberg B, Evans R. The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension. <em>Headache</em>. 55(1): 161-6. 2015</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">11. Jion Y, <strong>Raff A</strong>, Grosberg B, Evans R. Topiramate and nephrolithiasis: a response. <em>Headache</em>. 55(5): 710-2. 2015</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">12. Abramowitz, M, Melamed M, Bauer C, <strong>Raff A</strong>, Hostetter T. Effects of oral sodium bicarbonate in patients with CKD. <em>Clin J Am Soc Nephrol</em>. 8(5): 714-20. 2013</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">13. Berman N, Lectura M, Thurman J, Reinecke J, <strong>Raff A</strong>, Melamed M, Quan Z, Evans T, Meyer T, Hostetter T. A zebrafish model for uremic toxicity: role of the complement pathway. <em>Blood Purif</em>. 35(4): 265-9. 2013</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">14. Bomback A, <strong>Raff A</strong>. Olfactory function in dialysis patients: a potential key to understanding the uremic state. <em>Kidney Int</em>. 80(8): 803-5. 2011</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">15. Ponda M, Quan Z, Melamed M, <strong>Raff A</strong>, Meyer T, Hostetter T. Methylamine clearance by haemodialysis is low. <em>Nephrol Dial Transplant</em>. 25(5): 1608-13. 2010</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">16. <strong>Raff A</strong>, Lieu S, Melamed M, Quan Z, Ponda M, Meyer T, Hostetter T. Relationship of Impaired Olfactory Function in ESRD to Malnutrition and Retained Uremic Molecules. <em>Am J Kidney Dis</em>. 52(1): 102-10. 2008</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">17. <strong>Raff A</strong>, Meyer T, Hostetter T. New Insights into uremic toxicity. <em>Curr Opin Nephrol Hypertens</em>. 17(6): 560-5. 2008</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">18. Susztak K, <strong>Raff A</strong>, Schiffer M, Bottinger E. Glucose – induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. <em>Diabetes</em>. 55(1): 225-33. 2006</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">19. Schiffer M. Susztak K, Ranalletta M, <strong>Raff A</strong>, Bottinger E, Charron M. Localization of the GLUT8 transporter in murine kidney and regulation in vivo in non-diabetic and diabetic conditions. <em>Am J Physiol Renal Physiol</em>, 289(1): F186-193. 2005</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">20. <strong>Raff A</strong>, Hebert T, Pullman J, Coco M. Crescentic post-streptococcal glomerulonephritis with nephrotic syndrome in the adult: is aggressive therapy warranted? <em>Clinical Nephrology</em>, 63(5): 375-380. 2005</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">21. Spector M, <strong>Raff A</strong>, DeSilva H, Lee K, Osley M. Hir1p and Hir2p function as transcriptional corepressors to regulate histone gene transcription in <em>Saccharomyces cerevisiae </em>cell cycle. <em> Molecular and Cellular Biology</em>, 17(2): 545-552. 1997</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">22. Recht J, Dunn B, <strong>Raff A</strong>, Osley M. Functional analysis of histone H2A and H2B in transcriptional repression in <em>Saccharomyces cerevisiae. Molecular and Cellular Biology</em>, 16(6): 2545-2553<em>.</em> 1996</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 12pt; font-family: Cambria;">23. Kopczynski J, <strong>Raff A</strong>, Bonner J. Translational readthrough at nonsense mutations in the <em>HSF1</em> gene of <em>Saccharomyces cerevisiae. </em> <em>Molecular and General Genetics</em>, 234: 369-378. 1992</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: 'Times New Roman';"> </span></p>
<p>Amanda C. Raff, MD, is Attending Physician, Professor and Associate Chair of Medicine for Undergraduate Medical Education at Montefiore-Einstein. She is also the co-director of the Montefiore-Einstein Autosomal Dominant Polycystic Kidney Disease Program. Dr. Raff’s clinical focus is on dialysis and the treatment of patients with chronic kidney disease and end stage kidney disease.</p><p>After earning her Bachelor of Science in biology at Indiana University, Dr. Raff completed her Doctor of Medicine at Albert Einstein College of Medicine, earning her degree in 1998. Her postdoctoral training began at New York Presbyterian Hospital with an internship and residency in internal medicine from 1998 through 2001. She was assistant chief resident at Memorial Sloan Kettering Cancer Center in 2000 and chief resident at New York University Downtown Hospital from 2001 to 2002. She then returned to Montefiore-Einstein to complete a two-year fellowship in nephrology in 2004.</p><p>Dr. Raff’s research focuses on medical education. She has been the Course Director for the Einstein medical student Renal Course since 2007 and the Internal Medicine Clerkship and Acting Internship Director since 2012. Dr. Raff’s contributions in the field of Medical Education include serving as a Nephrology section committee member for the American College of Physicians’ Medical Knowledge Self-Assessment Program (MKSAP) 19 and 20 as well as prior work as a Case Editor for Aquifer Internal Medicine and contributing author and reviewer for the Clerkship Directors in Internal Medicine (CDIM) curriculum revision.</p><p>An enthusiastic medical educator, Dr. Raff has received several awards for her teaching and in 2010 was inducted into the Leo M. Davidoff Society for outstanding achievement in the teaching of medical students. She is board certified and is a member the American Society of Nephrology and a fellow of the American College of Physicians.</p>
Robert J. Ostfeld
<p>Dr. Robert Ostfeld is the founder and director of the Cardiac Wellness Program at Montefiore, an Associate Professor of Clinical Medicine and Albert Einstein College of Medicine, and the Associate Director of the Cardiology Fellowship at Einstein-Montefiore.</p>
<p>Dr. Ostfeld is the author of over 2 original articles and has authored numerous book chapters, reviews, and clinical statements. His professional interests include cardiovascular disease prevention, medical education, and clinical research. He speaks frequently to both the medical and lay community regarding cardiovascular disease prevention.</p>
<p>Dr. Ostfeld earned the outstanding Full-Time Attending of the Year award at Montefiore for excellence in teaching medical residents, received the Program Director's Award for dedicated service on behalf of the Montefiore Einstein Cardiology Fellowship, and was elected to the Leo M. Davidoff Society at Einstein for outstanding achievement in the teaching of medical residents.</p>
<p><strong>Education</strong></p>
<p>Undergraduate: University of Pennsylvania, 1992. Summa Cum Laude and Phi Beta Kappa </p>
<p>Medical School: Yale University School of Medicine, 1996. </p>
<p>Medical Internship: Massachusetts General Hospital, Harvard Medical School, 1996-1997. </p>
<p>Medical Residency: Massachusetts General Hospital, Harvard Medical School, 1997-1999. </p>
<p>Cardiology Fellowship: Brigham and Women's Hospital, Harvard Medical School, 1999-2003. </p>
<p>Research Fellowship in Preventive Medicine: Brigham and Women's Hospital, Harvard Medical School, 2002-2003. </p>
<p>Master's of Science in Epidemiology: Harvard School of Public Health, 2003. </p>
<p><strong>Clinical Research Interests</strong></p>
<p>Preventive Cardiology, General Cardiology, Valvular Heart Disease, Echocardiography, Medical Education</p>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Ostfeld treats patients with adult cardiovascular disease, including coronary artery disease, hypertension, hyperlipidemia, and erectile dysfunction with a focus on prevention and treatment through lifestyle change. He works closely with his patients to help them adopt a plant-based diet.</span>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Ostfeld’s research focus is on cardiovascular disease prevention and reversal through lifestyle modification. Ongoing topics he investigates include the impact of plant-based nutrition on erectile function, coronary artery disease, angina, and heart failure.</span>
<p>Robert J. Ostfeld, MD, MSc, FACC, is the Director of Preventive Cardiology at Montefiore Health System and a Professor of Medicine at the Albert Einstein College of Medicine. Dr. Ostfeld treats patients with adult cardiovascular disease, including coronary artery disease, hypertension, hyperlipidemia, and erectile dysfunction with a focus on prevention and treatment through lifestyle change. He works closely with his patients to help them adopt a plant-based diet.</p><p>Dr. Ostfeld received his Bachelor of Arts in the Biologic Basis of Behavior from the University of Pennsylvania, graduating Summa Cum Laude and Phi Beta Kappa and his Doctor of Medicine from Yale University School of Medicine. He then did his Medical Internship and Residency at the Massachusetts General Hospital and his Cardiology Fellowship and Research Fellowship in Preventive Medicince at Brigham and Women’s Hospital, both teaching hospitals of Harvard Medical School. During his Cardiology Fellowship, he earned a Master’s of Science in Epidemiology from the Harvard School of Public Health.</p><p>Dr. Ostfeld’s research focus is on cardiovascular disease prevention and reversal through lifestyle modification. Ongoing topics he investigates include the impact of plant-based nutrition on erectile function, coronary artery disease, angina, and heart failure. His work has been published in peer-reviewed journals, books, articles, and clinical statements and has been presented nationally.</p><p>Dr. Ostfeld is board certified in Cardiovascular Disease and Echocardiography and he is a member of numerous professional societies, including the Physician’s Committee for Responsible Medicine and the American College of Cardiology. </p>
E. Scott Monrad
Dr. Monrads' clinical focus is on interventional cardiology, hemodynamic assessment of valvular heart disease and hemodynamic assessment of congestive heart failure. He also has an interest in preventive cardiology in outpatients.
Dr. Monrad’s research focuses on improving clinical outcomes in patients with coronary artery disease.
<p>E. Scott Monrad, MD, CM, is Training Program Director, Cardiovascular Diseases; Director of Cardiovascular Quality; and Vice Chief of Cardiology, Patient Safety and Quality at Montefiore. He is also Professor of Clinical Medicine at our Albert Einstein College of Medicine. His clinical focus is on interventional cardiology, hemodynamic assessment of valvular heart disease and hemodynamic assessment of congestive heart failure. He also has an interest in preventive cardiology in outpatients.</p><p>After receiving his Bachelor of Arts from Harvard University in 1975, Dr. Monrad went on to receive his Doctor of Medicine and Master of Surgery in 1979 from McGill University Medical School in Montreal, Quebec. He attended New England Medical Center Hospital for the start of his postdoctoral training, completing an internship in medicine in 1980, and a residency in 1982. From 1982 to 1985, he was a fellow in the cardiovascular division at the Harvard Beth Israel Hospital in Boston, and from 1985 to 1986, he was a research fellow with the cardiology department at Medizinische Poliklinik, Universitaetsspital in Zurich, Switzerland.</p><p>Dr. Monrad’s research focuses on improving clinical outcomes in patients with coronary artery disease. His research findings have been published in many reviewed journals and abstracts. He has also contributed to many books.</p><p>Dr. Monrad has been included in Castle Connolly Top Doctors. He is board certified and is a member of several professional associations.</p>
Edwin C.W. Ho
Dr. Hos' clinical focus is on valvular heart disease, especially novel transcatheter valve repair and replacement technologies.
Following his clinical interests, Dr. Ho’s research focuses on valvular heart disease and advanced cardiac imaging. His research has been published in reviewed journals, and he has been invited to present and participate as faculty at several international cardiology and valve meetings.
<p>Edwin Ho, MD, is Co-Director of the Heart Valve/Structural Heart Center at Montefiore. His clinical focus is on valvular heart disease, especially novel transcatheter valve repair and replacement technologies.</p><p>In 2010, Dr. Ho received his Doctor of Medicine from the University of Toronto in Toronto, Ontario. He continued at the institution for his postdoctoral training with a three-year residency in general internal medicine from 2010 to 2013, followed by a three-year residency in adult cardiology, which he completed in 2016. He then pursued a clinical fellowship in echocardiography, interventional echocardiography and valvular heart disease at St. Michael’s Hospital in Toronto. After completing this in 2017, he continued his postdoctoral training at the University Hospital of Zurich in Switzerland, completing a clinical fellowship in interventional echocardiography and valvular heart disease in 2017 to 2019.</p><p>Following his clinical interests, Dr. Ho’s research focuses on valvular heart disease and advanced cardiac imaging. His research has been published in reviewed journals, and he has been invited to present and participate as faculty at several international cardiology and valve meetings. He has been an invited manuscript reviewer for <em>Circulation: Cardiovascular Imaging</em> and <em>Cardiovascular Medicine</em>.</p>
Mario J. Garcia
<p>Dr. Mario J. Garcia is an eminent cardiologist and leader in the development and clinical implementation of the most advanced noninvasive cardiac diagnostic technology used around the world today. A physician, researcher and educator, he is known worldwide for his innovative use of noninvasive cardiac imaging in the clinic, such as coronary CT angiography (including some of the earliest studies testing radiation-reduction strategies), echocardiography, and MRI.</p>
<p>Dr. Garcia’s research focuses on why patients with diastolic heart failure have trouble doing physical exercise and the role of screening imaging tests for predicting cardiovascular events such as heart attacks. His cardiac imaging work has contributed significantly to the diagnosis and treatment of coronary artery disease, diastolic heart failure, cardiomyopathies and valvular heart disease. The CT coronary angiography technique avoids the use of invasive arterial catheterization to image the coronary arteries, using instead a modified CT scanner to detect even the smallest atherosclerotic plaques that can cause narrowing of the coronary vessels and lead to deadly heart attacks. Dr. Garcia tested the technology in animal and controlled human studies, which led to increased accuracy and lowered the use of radiation, both of which improved clinical effectiveness. In addition, his research findings have helped to improve the safety of manned space flights and the quality of battlefield medicine.</p>
<p>Dr. Garcia joined Einstein/Montefiore as Chief of the Division of Cardiology in 2010. He holds the Pauline Levitt Endowed Chair in Medicine at Albert Einstein College of Medicine, and is Professor of Radiology and Co-Director (with Dr. Robert Michler) of the Montefiore-Einstein Center for Heart and Vascular Care. As co-director of the Center, Dr. Garcia has focused his attention on the cardiac health of lower income people living in urban areas such as the Bronx, where obesity, diabetes and other heart disease risk factors are common.</p>
<p>Dr. Garcia was born in Argentina and moved to the Dominican Republic when he was four years old. He attended Universidad Nacional Pedro Henriquez Urena in Santo Domingo, where he earned both his bachelor’s degree in premedical sciences and his doctorate in medicine, completing his formal education in 1986, when he moved to the United States to train as an internal medicine resident and then a cardiology fellow at St. Vincent’s Medical Center in Bridgeport, Connecticut. He then pursued additional training at Massachusetts General Hospital in Cardiac Nuclear Imaging and at the Cleveland Clinic in Advanced Cardiac Imaging.</p>
<p>After two years as an Assistant Professor at Dartmouth, Dr. Garcia was recruited to the Cleveland Clinic by Dr. Eric Topol (Scripps Research Institute, La Jolla, CA). He was initially a staff cardiologist, but became Director of Echocardiography in 2000, a position he held for the next five years. Under his tenure, the echocardiography program doubled in size to become the second largest program in the United States (behind the Mayo Clinic). Dr. Garcia was actively involved in recruiting new physicians to the program and managing the program’s budget. He also became involved in several entrepreneurial ventures, and brought CT angiography to the Cleveland Clinic. In 2005, he was named Director of Cardiovascular Imaging, leading the Cleveland Clinic to the top of cardiovascular imaging in the country at the time. In 2006, he was recruited to Mount Sinai as Professor of Medicine and Radiology and Director of the Cardiovascular Imaging Center, where he worked with Dr. Valentin Fuster. There, he once again led a successful expansion, developing a strong collaborative relationship with the Department of Radiology, a critical factor in his success.</p>
<p>Academically, Dr. Garcia is an active member of the Boards of Directors of the American Society of Nuclear Cardiology, of the Society of Cardiovascular Computed Tomography, and of the Intersocietal Accreditation Council, and he is a past member of the Board of the American Society of Echocardiography. He is a member of the American Heart Association, Circulation Council; a member of the Editorial Board, JACC-Imaging; the Associate Editor, American Heart Association on-line; the Editor of theheart.org Imaging section and the Editor in Chief of theheart.org (Spanish edition); a board member of the American Board of Internal Medicine (ABIM); and serves on the American College of Cardiology's ACCF Task Force on Clinical Expert Consensus Documents. He is the winner of the Feigenbaum Award of the American Society of Echocardiography (2004); the Inge Edler Award, Madrid, Spain (2001); the Teaching Attending of the year award, Cleveland Clinic Foundation (1998); the David H. Jacobs Research Award of the American Heart Association, Northeast Ohio Affiliate (1997); and the Facultad Universitaria Dominicana Year Award.<br />Dr. Garcia is the author or co-author of numerous books, including the very recent single-author definitive text, NonInvasive Cardiovascular Imaging: A Multimodality Approach (Garcia, MJ, Lippincott Williams & Wilkins, 2010). He has also written multiple book chapters and over 160 papers on many aspects of cardiac imaging.</p>
<p>Dr. Garcia's work has been supported by extramural funding from the National Space Biomedical Research Institute (NSBRI), the National Aeronautics and Space Administration (NASA), the Department of Defense (DOD), the American Society of Echocardiography, the NIH, the American Heart Association, and SmithKline Beecham Pharmaceuticals.</p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9pt; font-family: Arial, sans-serif; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Dr. Garcia is a physician, researcher and educator known for his innovative use of noninvasive cardiac imaging in the clinic, including CT angiography, echocardiography and MRI. His research focuses on why patients with diastolic heart failure have trouble doing physical exercise and the role of screening imaging tests for predicting cardiovascular events such as heart attacks. <span> </span></span><span style="font-size: 9.0pt; font-family: "Arial","sans-serif";"><br /> <br /> <span style="background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Dr. Garcia’s cardiac imaging work has contributed significantly to the diagnosis and treatment of coronary artery disease, diastolic heart failure, cardiomyopathies and valvular heart disease. In addition, his research findings have helped to improve the safety of manned space flights and the quality of battlefield medicine. As co-director of the Montefiore Einstein Center for Heart and Vascular Care, he has focused his attention on the cardiac health of lower income people living in urban areas such as the Bronx, where obesity, diabetes and other heart disease risk factors are common.</span></span></p>
Diagnosis and treatment of valvular heart disease, cardiomyopathies and pericardial disease.
Validation of non-invasive imaging for the study of cardiac structure and function.
<ol>
<li>Prasad A, Hastings JL, Shibata S, Popovic ZB, Arbab-Zadeh A, Bhella PS, Okazaki K, Fu Q, Berk M, Palmer D, Greenberg NL, Garcia MJ, Thomas JD, Levine BD. Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction. Circulation. Heart failure. 2010;3:617-626</li>
<li>Fernandez-Friera L, Garcia-Alvarez A, Bagheriannejad-Esfahani F, Malick W, Mirelis JG, Sawit ST, Fuster V, Sanz J, Garcia MJ, Hermann LK. Diagnostic value of coronary artery calcium scoring in low-intermediate risk patients evaluated in the emergency department for acute coronary syndrome. The American journal of cardiology. 2011;107:17-23</li>
<li>Romero J, Xue X, Gonzalez W, Garcia MJ. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: A meta-analysis of prospective trials. JACC. Cardiovascular imaging. 2012;5:494-508</li>
<li>Spevack DM, Karl J, Yedlapati N, Goldberg Y, Garcia MJ. Echocardiographic left ventricular end-diastolic pressure volume loop estimate predicts survival in congestive heart failure. Journal of cardiac failure. 2013;19:251-259.</li>
<li>Baber U, Mehran R, Sartori S, Schoos MM, Sillesen H, Muntendam P, Garcia MJ, Gregson J, Pocock S, Falk E and Fuster V. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. Journal of the American College of Cardiology. 2015;65:1065-74.</li>
</ol>
<p>Mario Jorge Garcia, MD, is Chief, Cardiology, Co-Director, Montefiore Einstein Center for Heart and Vascular Care and Professor, Medicine and Radiology at Montefiore Einstein. Dr. Garcia’s clinical expertise includes the diagnosis and treatment of valvular heart disease, cardiomyopathies and pericardial disease.</p><p>After completing his Bachelor in Premedical Sciences at Universidad Nacional Pedro Henriquez Ureña, Santo Domingo, Dominican Republic, Dr. Garcia continued at the institution to earn his Doctorate in Medicine in 1986. He completed a year as a physician assistant with the AIDS national research program at Laboratorio Nacional Dr. Defilló, Santo Domingo, Dominican Republic before coming to the United States for further training. At St. Vincent’s Medical Center, he completed his internal medicine residency in 1990 and his cardiology fellowship in 1992. In 1993, he completed his cardiac nuclear imaging fellowship at Massachusests General Hospital and Spaulding Rehabilitation Hospital, followed in 1994 by his advanced cardiac imaging fellowship at Cleveland Clinic Foundation.</p><p>Dr. Garcia’s research has focused on the validation of non-invasive imaging for the study of cardiac structure and function. He was a pioneer in the adaptation of multi-detector CT technology for coronary imaging. His research has been supported by extramural funding from the National Space Biomedical Research Institute, the National Aeronautics and Space Administration (NASA), the Department of Defense, the American Society of Echocardiography, the National Heart, Lung, and Blood Institute and the American Heart Association. He is the author or co-author of several books, book chapters and over 250 publications in peer-reviewed journals. He is also a reviewer for several national and international medical journals including <em>Journal of the American College of Cardiology, American Journal of Cardiology</em> and <em>Journal of the European Society of Cardiology.</em></p><p>Dr. Garcia is a Fellow of the American College of Cardiology and the American College of Physicians, and is a member of several other professional societies. He has received recognition nationally and internationally for his many accomplishments, including the Feigenbaum Award of the American Society of Echocardiography (2004), the Inge Edler Award, Madrid, Spain (2001), and the David H. Jacobs Research Award of the American Heart Association, Northeast Ohio Affiliate (1997).</p>
Carolyn Ann Bauer
<p>My goal is to develop a multi-disciplinary care center for patients with stage 3-4 chronic kidney disease. I plan to standardize care based on the recommendations of the kidney disease outcomes quality initiative. A database of information on the patients enrolled in the center will allow me to study factors that effect progression of chronic kidney disease, as well as test interventions to see if they improve kidney function. </p>
Chronic Kidney Disease, Kidney Stones, Polycystic Kidney Disease, Hypertension
Interdisciplinary chronic kidney disease management
<p><ol>
<li>Bauer C, Melamed ML, Hostetter TH. Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol. 2008 May;19(5):844-6</li>
<li>Melamed ML, Bauer C, Hostetter TH. eGFR: is it ready for early identification of CKD? Clin J Am Soc Nephrol. 2008 Sep;3(5):1569-72. Epub 2008 Jul 30.</li>
<li>Hartel D, Lo Y, Bauer C, Budner N, Howard AA, Floris-Moore M, Harnsten JH, Santoro N, Schoenbaum EE. Attitudes toward menopause in HIV-infected and at-risk women. Clin Interv Aging. 2008;3(3):561-6.</li>
<li>Bauer C, Abramowitz M, Hostetter TH. Is angiotensin system blockade indicated in the elderly? Nat Rev Nephrol. 2010 Jan;6(1):11-2.</li>
</ol></p>
Carolyn Bauer, MD, earned her medical degree at Albert Einstein College of Medicine in 2001. She completed her residency at New York Presbyterian-Cornell and was chief resident at NYU Downtown Hospital. She then completed her Nephrology Fellowship at Albert Einstein College of Medicine. Dr. Bauer is an Associate Professor of Medicine and is board certified by the American Board of Internal Medicine and the American Board of Nephrology. She is a member of the American Society of Nephrology and the National Kidney Foundation.